Sonia Fischer, Customer Integrations Manager, IQVIA
In the age of biotechnology, biosample collection has become an essential part of medical research. Through this process, samples are taken from patients through a variety of sources, including…
Continue Reading
The following is a guest article by Jon Kimerle, Global Strategic Healthcare Alliances at Pure Storage
The digital transformation of healthcare continues to accelerate, and technologies like artificial intelligence (AI) are predicted to have an…
What You Should Know:
The AI in Drug Discovery market in terms of revenue was estimated to be worth $600M in 2022 and is poised to reach $4B by 2027, growing at a CAGR of…
Continue Reading
The government and NHS England have confirmed their intention to relaunch England’s 15 Academic Health Science Networks (AHSNs) under the new name of Health Innovation Networks (HINs), to reflect their key role in supporting…
Continue Reading
Nathan Sommerford, Global Lead for Drug Discovery and Development, IQVIA
In an interview with HIT Consultant, Nathan Sommerford, Global Lead for Drug Discovery and Development, IQVIA talks how unlocking artificial intelligence (AI) in drug repurposing…
Continue Reading
Epic started out as a rather inert data repository, but decades of use and growth have allowed it to look beyond the EHR itself. According to Project Manager Erika Koch, they have taken on…
Continue Reading
What You Should Know:
ArisGlobal, a provider of life sciences software acquires SPORIFY, the trusted substances, products, organizations and referentials (SPOR) data harmonization technology solution for five of the world’s top 20 largest pharmaceutical companies….
Continue Reading
Pfizer and Colossal Biosciences are among the biotech and pharma firms already using two new suites of artificial intelligence tools unveiled this week by Google Cloud.WHY IT MATTERSThe new technologies, announced for general availability…
Continue Reading
The following is a guest interview with Romina Elias, Healthcare Chief Nursing Informatics Officer, and Jeff Kenkel, Global CTO for Life Sciences and Edge at Dell Technologies
The digital transformation of the healthcare industry is on…
At the annual AWS Life Sciences Executive Symposium, the company announced new Amazon Omics capabilities to help customers build, run and scale 35 Ready2Run workflows by Element Biosciences, NVIDIA and Sentieon Inc. WHY IT MATTERS
Large-scale…
